Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls

Ana Karina Aranda-Rivera, Alfredo Cruz-Gregorio, José Pedraza-Chaverri, Alexandra Scholze*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

35 Downloads (Pure)

Abstract

The nuclear factor erythroid 2-related factor 2 (Nrf2) protects the cell against oxidative damage. The Nrf2 system comprises a complex network that functions to ensure adequate responses to redox perturbations, but also metabolic demands and cellular stresses. It must be kept within a physiologic activity range. Oxidative stress and alterations in Nrf2-system activity are central for chronic-kidney-disease (CKD) progression and CKD-related morbidity. Activation of the Nrf2 system in CKD is in multiple ways related to inflammation, kidney fibrosis, and mitochondrial and metabolic effects. In human CKD, both endogenous Nrf2 activation and repression exist. The state of the Nrf2 system varies with the cause of kidney disease, comorbidities, stage of CKD, and severity of uremic toxin accumulation and inflammation. An earlier CKD stage, rapid progression of kidney disease, and inflammatory processes are associated with more robust Nrf2-system activation. Advanced CKD is associated with stronger Nrf2-system repression. Nrf2 activation is related to oxidative stress and moderate uremic toxin and nuclear factor kappa B (NF-κB) elevations. Nrf2 repression relates to high uremic toxin and NF-κB concentrations, and may be related to Kelch-like ECH-associated protein 1 (Keap1)-independent Nrf2 degradation. Furthermore, we review the effects of pharmacological Nrf2 activation by bardoxolone methyl, curcumin, and resveratrol in human CKD and outline strategies for how to adapt future Nrf2-targeted therapies to the requirements of patients with CKD.
Original languageEnglish
Article number1112
JournalAntioxidants
Volume11
Issue number6
Number of pages30
ISSN2076-3921
DOIs
Publication statusPublished - 3. Jun 2022

Keywords

  • Nrf2; oxidative stress; CKD; bardoxolone methyl; fibrosis; inflammation; NQO1; kidney function; hemodialysis; curcumin; redox signaling

Fingerprint

Dive into the research topics of 'Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls'. Together they form a unique fingerprint.

Cite this